Sandesh Seth, CEO at Actinium Pharmaceuticals, Inc. (ATNM), bought 10,000 shares at $0.79 ($8K) on 2018-07-17, disclosed to the SEC on 2018-07-17.
Open-market purchase of $8k ATNM by CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ATNM | BUY | 2017-08-04 | $25K | — | Filing → |
| ATNM | BUY | 2017-06-15 | $9K | — | Filing → |
| ATNM | BUY | 2017-01-03 | $4K | — | Filing → |